trump glp 1 deal GLP-1 price reduction: President announces to reduce costs Historic Drug Pricing Deal: Trump,

Fair editorial context for readers

Discover the transformative impact of GLP-1 agonists, originally a diabetes treatment, on thousands of peoples weight-loss journey.

SUMMARYIncretin therapy is based on the antidiabetic actions of the incretin hormone GLP-1

ICD-10 codes to identify the outcome are included in supplementary table S1

Lifestyle modification and nutrition-based approaches are regarded as the cornerstone strategies for treating pediatric obesity

Thanks to clinical trials that demonstrated a 12% weight-loss(1)and much buzzed about appetite-suppressing effects, the GLP-1 weight loss medications Wegovy and Zepbound, has been all over the news, and so has its high price tag